| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |